Shahryar Hashemzadeh

786 total citations
37 papers, 600 citations indexed

About

Shahryar Hashemzadeh is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Shahryar Hashemzadeh has authored 37 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Shahryar Hashemzadeh's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Trauma Management and Diagnosis (3 papers). Shahryar Hashemzadeh is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Trauma Management and Diagnosis (3 papers). Shahryar Hashemzadeh collaborates with scholars based in Iran, Australia and United States. Shahryar Hashemzadeh's co-authors include Behzad Baradaran, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh, Reyhaneh Ravanbakhsh Gavgani, Nasibeh Karimi, Behrooz Shokouhi, Shahram Teimourian, Nosratollah Zarghami, Mohamadreza Baghaban Eslaminejad and Abolfazl Barzegar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of Cellular Physiology.

In The Last Decade

Shahryar Hashemzadeh

33 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahryar Hashemzadeh Iran 14 250 183 170 131 108 37 600
Masato Okigami Japan 12 185 0.7× 147 0.8× 196 1.2× 122 0.9× 134 1.2× 37 569
Aki Isobe Japan 15 244 1.0× 175 1.0× 166 1.0× 62 0.5× 183 1.7× 25 800
Hiromitsu Komiyama Japan 10 198 0.8× 90 0.5× 142 0.8× 66 0.5× 73 0.7× 38 431
Daniel Pinďák Slovakia 12 174 0.7× 163 0.9× 285 1.7× 88 0.7× 55 0.5× 47 476
Klaus Aumayr Austria 12 229 0.9× 178 1.0× 285 1.7× 159 1.2× 74 0.7× 27 626
Ruitai Fan China 12 157 0.6× 146 0.8× 216 1.3× 86 0.7× 59 0.5× 31 476
Jingjing Guo China 13 159 0.6× 97 0.5× 96 0.6× 72 0.5× 67 0.6× 49 460
Xinyu Ti China 11 303 1.2× 128 0.7× 138 0.8× 58 0.4× 94 0.9× 28 629
Yoon Hee Kang South Korea 10 264 1.1× 159 0.9× 142 0.8× 59 0.5× 63 0.6× 16 550
Jinmei Su China 14 267 1.1× 175 1.0× 135 0.8× 51 0.4× 217 2.0× 47 764

Countries citing papers authored by Shahryar Hashemzadeh

Since Specialization
Citations

This map shows the geographic impact of Shahryar Hashemzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahryar Hashemzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahryar Hashemzadeh more than expected).

Fields of papers citing papers by Shahryar Hashemzadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahryar Hashemzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahryar Hashemzadeh. The network helps show where Shahryar Hashemzadeh may publish in the future.

Co-authorship network of co-authors of Shahryar Hashemzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Shahryar Hashemzadeh. A scholar is included among the top collaborators of Shahryar Hashemzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahryar Hashemzadeh. Shahryar Hashemzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashemzadeh, Shahryar, et al.. (2023). Effect of erythropoietin on inflammatory response and ischemic brain damage after carotid artery clamp in rat. SHILAP Revista de lepidopterología. 11. 1–1.
2.
Zafari, Venus, et al.. (2023). Evaluation of Expression Levels of NFATc2 and PPARG Genes Two Effector Elements of WNT Pathway in Non-Small Cell Lung Carcinoma. SHILAP Revista de lepidopterología. 12(1). 184–184. 1 indexed citations
3.
Derakhshani, Afshin, Shahryar Hashemzadeh, Zahra Asadzadeh, et al.. (2021). Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine. Cancers. 13(10). 2414–2414. 64 indexed citations
4.
Baghbani, Elham, Saeed Noorolyai, Pascal H. G. Duijf, et al.. (2021). The impact of microRNAs on myeloid-derived suppressor cells in cancer. Human Immunology. 82(9). 668–678. 5 indexed citations
5.
Baradaran, Behzad, et al.. (2020). The Correlation Between Helicobacter pylori Infection and Lnc-OC1 Expression in Gastric Cancer Tissues in an Iranian Population. Journal of Gastrointestinal Cancer. 52(2). 600–605. 8 indexed citations
6.
Javadrashid, Reza, et al.. (2020). The diagnostic value of diffusion-weighted imaging in differentiating benign from malignant hepatic lesions. SHILAP Revista de lepidopterología. 10(1). 5 indexed citations
7.
Safarzadeh, Elham, Shahryar Hashemzadeh, Pascal H. G. Duijf, et al.. (2018). Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer. Journal of Cellular Physiology. 234(4). 3515–3525. 64 indexed citations
8.
Estiar, Mehrdad A., et al.. (2018). Deregulated expression of HDAC3 in colorectal cancer and its clinical significance. Advances in Clinical and Experimental Medicine. 27(3). 305–311. 34 indexed citations
9.
Feizi, Mohammad Ali Hosseinpour, et al.. (2016). Prognostic and predictive roles of microRNA-383 in colorectal cancer. Gastroenterology Insights. 7(1). 9 indexed citations
10.
Tubbs, R. Shane, et al.. (2015). Analysis of the Profunda Femoris Artery with Superficial Femoral Artery Occlusive Disease. 1(2).
11.
Hashemzadeh, Shahryar. (2014). Surgical and Non-Surgical Management of Endoscopic Retrograde Cholangiopancreatography Complications. SHILAP Revista de lepidopterología. 6(4).
12.
Hashemzadeh, Shahryar, et al.. (2014). Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer. Medical Oncology. 31(10). 237–237. 14 indexed citations
14.
Sayyah-Melli, Manizheh, et al.. (2013). Comparison of Platinum-based Neoadjuvant Chemotherapy and Primary Debulking Surgery in Patients with Advanced Ovarian Cancer. The Journal of Obstetrics and Gynecology of India. 63(6). 405–409. 6 indexed citations
15.
Hashemzadeh, Shahryar, et al.. (2012). Pleurodesis by erythromycin, tetracycline, Aerosil™ 200, and erythromycin plus Aerosil™ 200 in a rat model: a preliminary study. DARU Journal of Pharmaceutical Sciences. 20(1). 79–79. 10 indexed citations
16.
Hashemzadeh, Shahryar, et al.. (2012). Risk factors and outcomes of acute renal failure after open cardiac surgery. Asian Cardiovascular and Thoracic Annals. 20(3). 275–280. 8 indexed citations
17.
Hashemzadeh, Shahryar, et al.. (2011). Nonoperative management of anterior thoracoabdominal stab wounds in selected patients. European Journal of Emergency Medicine. 19(2). 77–82. 3 indexed citations
19.
Hashemzadeh, Shahryar, et al.. (2009). Epidemiological Study of Lung Cancer in East Azerbaijan, Iran. Journal of Cardiovascular and Thoracic Research. 1(4). 7–12. 4 indexed citations
20.
Hashemzadeh, Shahryar, et al.. (2007). Congenital malformations of the lung. The Indian Journal of Pediatrics. 74(2). 192–194. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026